Bragar Eagel & Squire, P.C. is investigating Kemper Corporation for potential violations of federal securities laws following a 10% drop in its stock price. The decline occurred after Kemper disclosed increased attorney involvement and loss costs due to higher minimum liability limits effective January 2025. Investors who suffered losses or have information are encouraged to contact the law firm to discuss their legal rights. The investigation aims to determine if Kemper engaged in unlawful business practices affecting shareholders.
Ultragenyx Pharmaceutical Inc. awarded 44,409 restricted stock units to 15 newly hired non-executive officers under its Employment Inducement Plan. The grants, approved by the compensation committee, vest over four years with 25% vesting annually, co...
Nyxoah has announced an extraordinary general meeting of shareholders set for July 9, 2026, at its headquarters in Belgium. The meeting will discuss renewing the authorization for the board to increase the company's capital over the next five years, ...
Eupraxia Pharmaceuticals held its Annual General Meeting on June 18, 2026, where shareholders elected all seven board nominees proposed by management with strong majority votes. Additionally, KPMG LLP was reappointed as the company's auditor for the ...
Cate & Chloe is discounting its Bianca 18k Gold-Plated Crystal Hoop Earrings to $19.98 from $86 during Amazon Prime Day 2026, running June 23-26. This 77% markdown aligns with growing consumer demand for affordable luxury jewelry, with earrings price...
Europe's upcoming 2027 crypto regulations, including a €10,000 cash payment limit and stricter crypto transaction rules, have intensified discussions about financial privacy and privacy coins like Zcash. Initial fears about mandatory identity checks ...
